Go to full publication
Serological biomarkers of joint tissue turnover predict tocilizumab response at baseline.
September 1, 2014
J Clin Rheumatol
Publications
Active filters
Add filters (0)
2 results
September 1, 2014
J Clin Rheumatol
Go to full publication
January 1, 2013
PLoS One
Abstract Inflammation driven connective tissue turnover is key in rheumatic diseases, such as ankylosing spondylitis (AS). Few biomarkers are available for measuring disease prognosis or the efficacy of interventions applied in these tissue-related conditions. Type II collagen is the primary structural protein of cartilage and type III collagen of connective tissues, and obvious targets for […]